Report cover image

Global Constipation Treatment Market -Global Trends and Forecasts(2025 to 2034)

Publisher Factview Research
Published Nov 02, 2025
Length 104 Pages
SKU # FAVR20572930

Description

Constipation Treatment Market Size And Forecast

According to Factview Research, the Global Constipation Treatment Market was valued at USD 15.83 Billion in 2024 and is projected to reach USD 32.12 Billion by 2034, growing at a CAGR of 8.1% from 2025 to 2034.

Global Constipation Treatment Market Outlook

Increasing geriatric population in developing countries including the U.S., Germany, Japan along with changing dietary habits are resulting in the stimulated prevalence of chronic constipation disease, which in turn, propelling the growth of the Global constipation treatment market. Furthermore, rising R&D activities by market vendors for the development of new drugs and effective treatment is providing lucrative growth opportunities to the Global market over the forecast period.

Global Constipation Treatment Market Competitive Landscape

The Global Constipation Treatment Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Takeda Pharmaceutical Company Ltd., Synergy Pharmaceuticals, Inc., Abbott Laboratories, AstraZeneca, and Bayer AG.

Table of Contents

104 Pages
1 Introduction Of Global Constipation Treatment Market
1.1 Overview Of The Market
1.2 Scope Of Report
1.3 Assumptions
2 Executive Summary
3 Research Methodology Of Factview Research
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List Of Data Sources
4 Global Constipation Treatment Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Constipation Treatment Market, By Disease Type
5.1 Overview
5.2 Chronic Idiopathic Constipation (Cic)
5.3 Irritable Bowel Syndrome With Constipation (Ibs-c)
5.4 Opioid-induced Constipation (Oic)
6 Global Constipation Treatment Market, By Therapeutic Option
6.1 Overview
6.2 Laxatives
6.3 Chloride Channel Activators
6.4 Peripherally Acting Mu-opioid Receptor Antagonists
6.5 Gc-c Agonists
6.6 5-ht4 Receptor Agonists
7 Global Constipation Treatment Market, By Distribution Channel
7.1 Overview
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies
8 Global Constipation Treatment Market, By Geography
8.1 Overview
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest Of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest Of Asia Pacific
8.5 Rest Of The World
8.5.1 Latin America
8.5.2 Middle East
9 Global Constipation Treatment Market Competitive Landscape
9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies
10 Company Profiles
10.1 Takeda Pharmaceutical Company Ltd
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Synergy Pharmaceuticals, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 Ironwood Pharmaceuticals, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Salix Pharmaceuticals
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Abbott Laboratories
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 Astrazeneca
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Cosmo Pharmaceuticals Nv
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
10.8 Sanofi
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments
10.9 Bayer Ag
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments
11 Appendix
11.1 Related Research

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us